Reducing the global burden of HTLV-1 infection: An agenda for research and action.
about
Dendritic cell maturation, but not type I interferon exposure, restricts infection by HTLV-1, and viral transmission to T-cells.Human T-cell lymphotropic virus type 1 and its oncogenesis.Time to Go Back to the Original Name.Human T-Cell Leukemia Virus Type 1 Infection and Adult T-Cell Leukemia.Prevalence of Human T-lymphotropic virus type 1 and 2 among blood donors in Manaus, Amazonas State, Brazil.Control of Human T-Cell Leukemia Virus Type 1 (HTLV-1) Infection by Eliminating Envelope Protein-Positive Cells with Recombinant Vesicular Stomatitis Viruses Encoding HTLV-1 Primary Receptor.How Does HTLV-1 Undergo Oncogene-Dependent Replication Despite a Strong Immune Response?Sporadic on/off switching of HTLV-1 Tax expression is crucial to maintain the whole population of virus-induced leukemic cells.HTLV-1, the Other Pathogenic Yet Neglected Human Retrovirus: From Transmission to Therapeutic Treatment.Mitochondrial Proteins Coded by Human Tumor Viruses.HTLV Deregulation of the NF-κB Pathway: An Update on Tax and Antisense Proteins Role.Risk factors associated with HTLV-1 vertical transmission in Brazil: longer breastfeeding, higher maternal proviral load and previous HTLV-1-infected offspring.How to Control HTLV-1-Associated Diseases: Preventing de Novo Cellular Infection Using Antiviral Therapy.Low prevalence of HTLV1/2 infection in a population of immigrants living in southern Italy.Fine-scale geographic clustering pattern of human T-cell leukemia virus type 1 infection among blood donors in Kyushu-Okinawa, Japan.
P2860
Q36352268-A75294E5-6E80-4B4C-AFD7-46089FC71A02Q38732770-8727439B-D1F0-44DB-9FB3-A5ECF3277137Q41919668-D3C361FA-C4B3-4F69-A93B-E51E1711BD2AQ45325985-3B0AF741-3D3C-4F9A-B41B-964566FBFFC9Q47106331-185A62DF-3A00-4683-BE26-E43A0DF50948Q47322109-7BA10F67-D88F-4110-A5F7-4BBC84E4B7C2Q47548079-C45FCED8-85A3-4F6E-AC05-024C38EA0761Q47550200-ABEE3456-4CCB-4040-811F-502B02809AC7Q47562043-8B232288-020E-4555-BF69-356858193921Q50320474-CE67EC9D-56DA-4645-86AD-39C2899B6226Q52728051-D213024A-EE6A-407C-903B-AB07302E7366Q54207397-6DC97120-5654-4F7F-B36A-1A6B0BA22A4DQ54246489-4311459B-7C33-4E35-85E4-8093CE75C7F6Q55239037-19DEBFCB-DF2C-475D-8200-D8FA858812BFQ55239042-910EE632-A331-4751-86E3-85BD0D6B63AE
P2860
Reducing the global burden of HTLV-1 infection: An agenda for research and action.
description
2016 nî lūn-bûn
@nan
2016 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Reducing the global burden of HTLV-1 infection: An agenda for research and action.
@ast
Reducing the global burden of HTLV-1 infection: An agenda for research and action.
@en
type
label
Reducing the global burden of HTLV-1 infection: An agenda for research and action.
@ast
Reducing the global burden of HTLV-1 infection: An agenda for research and action.
@en
prefLabel
Reducing the global burden of HTLV-1 infection: An agenda for research and action.
@ast
Reducing the global burden of HTLV-1 infection: An agenda for research and action.
@en
P2093
P50
P1433
P1476
Reducing the global burden of HTLV-1 infection: An agenda for research and action.
@en
P2093
Anna Barbara de Freitas Carneiro-Proietti
Calum Macpherson
Eduardo Gotuzzo
Edward Murphy
Graham P Taylor
Hideki Hasegawa
Jordana Coelho-Dos-Reis
Joseph Harford
José Esparza
P356
10.1016/J.ANTIVIRAL.2016.10.015
P50
P577
2016-11-10T00:00:00Z